Nanosonics Limited (NNCSF)

Market Cap	817.58M
Revenue (ttm)	113.85M
Net Income (ttm)	10.25M
Shares Out	n/a
EPS (ttm)	0.03
PE Ratio	79.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	1,566
Open	2.650
Previous Close	2.650
Day's Range	2.650 - 2.650
52-Week Range	1.724 - 2.890
Beta	1.73
RSI	60.61
Earnings Date	Feb 19, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNCSF

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.

Financial numbers in AUD